1,008
Participants
Start Date
January 4, 2016
Primary Completion Date
July 3, 2018
Study Completion Date
April 4, 2019
Cisatracurium Besylate
Patients randomized to the early neuromuscular blockade arm will receive a cisatracurium besylate bolus of 15 mg, followed by a continuous infusion of 37.5 mg/hour for 48 hours. Patients randomized to the control arm will receive no protocol specified neuromuscular blockade.
Mt. Sinai Hospital, New York
Montefiore Medical Center, The Bronx
UPMC Presbyterian/Mercy/Shadyside, Pittsburgh
Penn State Hershey Medical Center, Hershey
University or Virginia Health System, Charlottesville
VCU Medical Center, Richmond
Wake Forest Baptist Medical Center, Winston-Salem
Wesley Long Hospital, Greensboro
Vanderbilt University Medical Center, Nashville
University of Mississippi Medical Center, Jackson
Ohio State University Wexner Medical Center, Columbus
Cleveland Clinic Foundation, Cleveland
Summa Akron City Hospital, Akron
University of Cincinnati Medical Center, Cincinnati
Indiana University Methodist Hospital, Indianapolis
Henry Ford Medical Center, Detroit
University of Michigan Medical Center, Ann Arbor
University Medical Center, New Orleans
Medical Center of Aurora, Aurora
University of Colorado Hospital, Aurora
Swedish Medical Center, Englewood
Denver Health Medical Center, Denver
Intermountain Medical Center, Murray
University Hospital, Salt Lake City
LDS Hospital, Salt Lake City
McKay-Dee Hospital, Ogden
Utah Valley Regional Medical Center, Provo
Ronald Reagan UCLA Medical Center, Los Angeles
UCSF Fresno, Fresno
UCSF Medical Center, San Francisco
Stanford University Hospital, Stanford
UC Davis Medical Center, Sacramento
Oregon Health and Science University, Portland
Harborview Medical Center, Seattle
University of Washington Medical Center, Seattle
Swedish Hospital Cherry Hill, Seattle
Swedish Hospital First Hill, Seattle
Maine Medical Center, Portland
Tufts Medical Center, Boston
Massachusetts General Hospital, Boston
Brigham and Women's Hospital, Boston
Beth Israel Deaconess Medical Center, Boston
Baystate Medical Center, Springfield
St. Vincent's Hospital, Worcester
National Heart, Lung, and Blood Institute (NHLBI)
NIH
Massachusetts General Hospital
OTHER